C
Cipher Gene Tech
Cipher Gene Tech is a bio medical big data analysis and interpretation platform
About Cipher Gene Tech
Established in October 2015, Cipher Gene Tech operates at the intersection of genomics and artificial intelligence, positioning itself as a precision medicine service provider. The company, with headquarters in Beijing, China, and Lewes, Delaware, in the US, focuses on developing an automated platform for the analysis and interpretation of genetic data. Its primary market consists of third-party research institutes, universities, and hospitals. Cipher Gene Tech generates revenue by providing high-quality data analysis, support services, and genetic testing products related to inherited diseases and cancer to these institutions.
The core of the company's offering is an intelligent platform designed to automate and visualize the interpretation of complex genetic data, aiming to enhance the accuracy of clinical diagnoses. This service is particularly focused on the field of childhood genetic diseases, where it assists physicians in making more efficient and precise treatment decisions. The business model hinges on collaboration; by working closely with clinical doctors and research organizations, Cipher Gene continually refines its algorithms and workflows. The company has successfully navigated multiple funding rounds, including a seed round in February 2016 and a Series C round in May 2024, accumulating total funding of over $30 million.
Cipher Gene Tech's platform is supported by a multidisciplinary team with expertise in bioinformatics, molecular biology, genetics, and statistics. This integrated team is responsible for testing, optimizing, and integrating the various algorithms and protocols necessary for analyzing different types of genetic data. The company operates within the Laboratory Services (Healthcare) industry, with a vertical focus on Artificial Intelligence & Machine Learning, Life Sciences, and Oncology. Investors include entities such as Jinjiang Development, Tsinghua Innovation Ventures, and TusStar Incubator, reflecting confidence in its specialized market approach.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Dongcheng District, China
- Employees
- 9
- Open positions
- None listed
- Dealroom signal
- 55.1/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Developer Tools, Biotechnology, Hard Tech, DT and LS, science-based
- Technology
- Big Data, Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | May 2024 | $14M | $55M | Jinjiang Development Group · Zhongxi Fund | ↗ |
| SERIES BEquity / VC | Jul 2020 | — | — | CS Capital | ↗ |
Growth signals
Latest recorded traffic for Cipher Gene Tech is 980 monthly website visits, up 444.4% over the last three months. Cipher Gene Tech's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Shenzhen Guozhong Venture Capital Management
CS Capital
Series B and later2 investors entered at this stage
- JGJinjiang Development Group
Zhongxi Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cipher Gene Tech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cipher Gene Tech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






